Skip to Content

RHA® Resilient Hyaluronic Acid®

Revance is an exclusive U.S. commercialization partner of TEOXANE SA's RHA® (Resilient Hyaluronic Acid®), the latest advancement in filler technology.

First and Only FDA-Approved Dermal Filler for Correction of Dynamic Facial Wrinkles and Folds

RHA® 2 and RHA® 3 are indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older.

RHA® 4 is indicated for injection into the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older.

Back to top